Neurology

ECTRIMS 2025 slide resource

September 25, 2025  

The 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis – 24-26 September 2025

Please note that the NeuroSens ECTRIMS 2025 Highlights slide resource, developed in collaboration with Dr. Daniel Selchen, Toronto, will be available as of October 17th, on request only.  Make your request now by completing the online form.  Industry members can also use this form to request to sponsor a NeuroSens post-ECTRIMS event (in-person or virtual). For more information, contact us at info@neuro-sens.com. Read More

ECTRIMS 2025 survey

September 4, 2025  

NeuroSens will be providing daily coverage of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2025 annual meeting, to be held September 24-26 in Barcelona, Spain. Read More

Baseline sNfL prognostic of disease activity in CIS

August 21, 2025  

Higher baseline levels of serum neurofilament-light chain (sNfL) are prognostic of disease activity in patients with clinically isolated syndrome, according to a retrospective analysis of 181 individuals presenting with CIS at two MS centres in Spain during the period 2004-2022 (Comabella et al. Neurol Neuroimmunol Neuroinflamm 2025;12:e200370). Read More

EAN HIGHLIGHTS – TUESDAY, JUNE 24, 2025

June 24, 2025  

Monday Edition

The following summarizes some additional highlights from the 11th Congress of the European Academy of Neurology, Helsinki, Finland, June 21-24, 2025.

Genetics affect MS risk, not clinical course
GFAP increases with normal aging
Midbrain lesions associated with migraine in MS
When to switch off anti-CGRP MAbs for migraine
Serial sNfL monitoring needed for correct interpretation
Specialists outperform Chat GPT
Read More